• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Health In Tech Announces Innovative Collaboration with MARPAI and Vitable DPC to Offer Competitive Quotes in Enhanced Self-Funded Solutions

    1/22/25 5:00:00 PM ET
    $HIT
    $MRAI
    Specialty Insurers
    Finance
    Misc Health and Biotechnology Services
    Health Care
    Get the next $HIT alert in real time by email

    STUART, Fla., Jan. 22, 2025 /PRNewswire/ -- Health In Tech, an Insurtech platform company backed by third-party AI technology, is thrilled to announce a new strategic collaboration with Vitable and MARPAI. This collaboration aims to introduce a  competitively priced self-funded health plan to the market. By utilizing the strength of Vitable's Direct Primary Care (DPC), a health plan, and stop-loss coverage, Health In Tech seeks to offer low quotes on their eDIYBS platform, and to set an ambitious standard in affordability and efficiency.

    HIT logo (PRNewsfoto/Health In Tech)

    Vitable's enhanced primary care plan combines in-person and virtual primary care access with mental health programs, free prescription drugs, lab work, and care navigation for the entire household, all under a low monthly fee and $0 out-of-pocket cost for members. With their cost containment ability proven by numerous third-party actuarial firms and reinsurance carriers, our intention is to utilize Vitable's DPC to provide competitively priced quotes within Health In Tech's proprietary eDIYBS platform for networks and carriers under MARPAI's self-funded health plan offerings. We expect Vitable's high utilization and member satisfaction to contribute to reductions in healthcare costs.

    "This collaboration exemplifies our commitment to revolutionizing healthcare access and affordability," said Glenn Hillyer, Chief Growth Officer at Health In Tech. "By integrating Vitable's hybrid DPC model - with their successful track record in effectively managing primary care and urgent care claims for self-funded and level-funded plans - with MARPAI's self-funded health plans, and the streamlined process for which Health In Tech is known for, we are working to deliver competitive value and comprehensive care to our clients."

    Vitable's hybrid DPC model seeks to ensure seamless access to primary care and mental health services, providing members with the flexibility and convenience of both in-home and virtual visits. This approach addresses the critical need for accessible and affordable healthcare, especially for the under- and uninsured workforce.

    "We are excited to join forces with Health In Tech and MARPAI to bring our high-quality health plans at a significantly lower cost," said Steven Baek, Head of Growth at Vitable. "Our commitment is to enhance member satisfaction and utilization while driving down healthcare costs."

    "We are excited to announce our collaboration with both Health In Tech and Vitable, two leaders in the employee benefits space," said Ben Utz, Vice President of Strategic Accounts at Marpai. "Together, we hope to deliver smarter, seamless healthcare experiences that prioritize employee well-being, improve access to personalized care, and drive meaningful results for organizations."

    This competitive quote opportunity will be available through Health In Tech's eDIYBS platform starting today.

    About Health In Tech

    Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

    About Vitable

    Vitable offers a hybrid Direct Primary Care health plan for self-funded and level-funded groups, delivering easy access to high-quality primary care and mental health coverage to the under- and uninsured American workforce. Vitable membership includes in-home and virtual primary care visits, free prescriptions, labs, and mental health programs with no out-of-pocket cost for the members.

    About Marpai, Inc.

    Marpai, Inc. (OTCQX:MRAI) is a technology platform company which operates subsidiaries that provide TPA and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $22 billion TPA sector serving self-funded employer health plans representing over $1 trillion in annual claims. Through its Marpai Saves initiative, the Company works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna, industry leading Reference Based Pricing (RBP) solutions and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://www.ir.marpaihealth.com.

    Forward-Looking Statements Regarding Health In Tech

    Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

    Investor Contact

    Investor Relations:

    ir@healthintech.com

     

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-innovative-collaboration-with-marpai-and-vitable-dpc-to-offer-competitive-quotes-in-enhanced-self-funded-solutions-302357907.html

    SOURCE Health In Tech

    Get the next $HIT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HIT
    $MRAI

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $HIT
    $MRAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Marpai Inc. Announces Unprecedented Growth with 192,000 New Estimated Member Lives Across TPA and MarpaiRx PBM Platforms; Expects to Achieve Positive Cash Flow and EBITDA Beginning August 2026

    TAMPA, Fla., May 26, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration ("TPA"), and Pharmacy Benefit Management ("PBM") services, today announced a historic expansion of its business book. Following a series of newly secured commitments and confirmed new business across its Third-Party Administrator (TPA) and MarpaiRx Pharmacy Benefit Management (PBM) platforms, the Company estimates a total increase of 192,000 member lives scheduled to roll out between August 2026 and January 2027.This influx represents a nearly six-fold increase in the Company's current member lives, potentially transforming

    5/26/26 4:07:00 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

    Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 ProfitabilityTAMPA, Fla., May 15, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management ("PBM") services, announced the financial results for the first quarter 2026.Marpai's first quarter 2026 results reflect the Company's continued execution of its operational transformation designed to position the business for profitability and growth. The Company has nearly completed the migration of its IT and claims processing to a single, unified cloud-bas

    5/15/26 4:03:00 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Health In Tech Reports First Quarter 2026 Financial Results

    Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 MillionSTUART, Fla., May 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (NASDAQ:HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three months ended March 31, 2026. First Quarter 2026 OverviewRevenue increased 9.4% to $8.8 million from $8.0 million in the first quarter of 2025.Platform placed plan value1 totaled $82.0 million.Adjusted EBITDA2 totaled $(1.3) million, compared to $1.2 million in the first quarter of 20

    5/13/26 4:00:00 PM ET
    $HIT
    Specialty Insurers
    Finance

    $HIT
    $MRAI
    SEC Filings

    View All

    Amendment: SEC Form S-3/A filed by Health In Tech Inc.

    S-3/A - Health In Tech, Inc. (0002019505) (Filer)

    5/22/26 4:15:48 PM ET
    $HIT
    Specialty Insurers
    Finance

    SEC Form 10-Q filed by Marpai Inc.

    10-Q - Marpai, Inc. (0001844392) (Filer)

    5/15/26 4:16:21 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 10-Q filed by Health In Tech Inc.

    10-Q - Health In Tech, Inc. (0002019505) (Filer)

    5/14/26 4:34:22 PM ET
    $HIT
    Specialty Insurers
    Finance

    $HIT
    $MRAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Eitan Yaron returned 50,000 shares to the company and was granted 175,000 shares, decreasing direct ownership by 4% to 1,224,073 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    6/2/26 5:02:06 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Chief Financial Officer Johnson Steve Andrew was granted 125,000 shares and bought $682 worth of shares (1,100 units at $0.62), increasing direct ownership by 14% to 1,024,192 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    6/2/26 5:01:11 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Director Shiv Sagiv returned 50,000 shares to the company and was granted 125,000 shares, decreasing direct ownership by 8% to 613,667 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    6/2/26 5:00:16 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $HIT
    $MRAI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Johnson Steve Andrew was granted 125,000 shares and bought $682 worth of shares (1,100 units at $0.62), increasing direct ownership by 14% to 1,024,192 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    6/2/26 5:01:11 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Director Eitan Yaron bought $2,700 worth of shares (10,000 units at $0.27), increasing direct ownership by 0.92% to 1,099,073 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    5/22/26 4:02:13 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Director Eitan Yaron bought $100,000 worth of shares (100,000 units at $1.00), increasing direct ownership by 10% to 1,089,073 units (SEC Form 4)

    4 - Marpai, Inc. (0001844392) (Issuer)

    11/12/25 6:50:17 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $HIT
    $MRAI
    Financials

    Live finance-specific insights

    View All

    Health In Tech Reports First Quarter 2026 Financial Results

    Reiterates Guidance for 2026 Annual Revenue Ranging between $45 Million and $50 MillionSTUART, Fla., May 13, 2026 /PRNewswire/ -- Health In Tech, Inc. (NASDAQ:HIT) ("Health In Tech" or "Company"), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three months ended March 31, 2026. First Quarter 2026 OverviewRevenue increased 9.4% to $8.8 million from $8.0 million in the first quarter of 2025.Platform placed plan value1 totaled $82.0 million.Adjusted EBITDA2 totaled $(1.3) million, compared to $1.2 million in the first quarter of 20

    5/13/26 4:00:00 PM ET
    $HIT
    Specialty Insurers
    Finance

    Health In Tech to Announce First Quarter 2026 Financial Results on May 13, 2026

    STUART, Fla., April 30, 2026 /PRNewswire/ -- Health In Tech, Inc. (NASDAQ:HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the first quarter ended March 31, 2026, following the close of market on Wednesday, May 13, 2026. Health In Tech will host a conference call and live webcast to discuss the Company's financial results, recent developments and business outlook. Event: Health In Tech's First Quarter 2026 Earnings Conference CallWhen: Wednesday, May 13, 2026, at 5:00 p.m. ETLive Call:PARTICIPANT DIAL IN (TOLL FREE): 1-88

    4/30/26 4:01:00 PM ET
    $HIT
    Specialty Insurers
    Finance

    Health In Tech to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

    STUART, Fla., March 9, 2026 /PRNewswire/ -- Health In Tech, Inc. (NASDAQ:HIT), an AI-enabled InsurTech platform company, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2025, following the close of market on Wednesday, March 25, 2026. Health In Tech will host a conference call and live webcast to discuss the Company's financial results, recent developments and business outlook. Event: Health In Tech's Fourth Quarter and Full Year 2025 Earnings Conference CallWhen: Wednesday, March 25, 2026, at 5:00 p.m. ETLive Call:PARTICIPANT DIAL IN (TOLL FREE): 1-888-346-8982PARTICIPANT INTERNATIONAL DIAL IN: 1-412-902-4272Webcast Link:https:/

    3/9/26 7:00:00 AM ET
    $HIT
    Specialty Insurers
    Finance

    $HIT
    $MRAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    9/4/24 7:55:41 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13D/A filed by Marpai Inc. (Amendment)

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    5/29/24 4:01:02 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    $HIT
    $MRAI
    Leadership Updates

    Live Leadership Updates

    View All

    MARPAI REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS

    Strategic Investments in Operations and Technology Fuel Platform for Accelerated Growth and Aim of Second-Half 2026 ProfitabilityTAMPA, Fla., May 15, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management ("PBM") services, announced the financial results for the first quarter 2026.Marpai's first quarter 2026 results reflect the Company's continued execution of its operational transformation designed to position the business for profitability and growth. The Company has nearly completed the migration of its IT and claims processing to a single, unified cloud-bas

    5/15/26 4:03:00 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care

    Health In Tech Appoints Former SAP and IBM Executive Sri Rajagopalan as Chief Technology Officer to Advance AI-driven Enterprise-Grade Platform Growth

    STUART, Fla., Feb. 24, 2026 /PRNewswire/ -- Health In Tech, Inc. (NASDAQ:HIT), an AI-enabled InsurTech platform company, today announced the appointment of Sri Rajagopalan as Chief Technology Officer (CTO), effective February 23, 2026. Mr. Rajagopalan has served as Health In Tech's Interim CTO since November 2025, during which time he has provided decisive technology leadership and advanced the company's AI-driven transformation strategy. As Interim CTO, he has strengthened architectural discipline, accelerated platform modernization, and delivered measurable execution across mission-critical technology initiatives.As Chief Technology Officer, Mr. Rajagopalan oversees end-to-end product engi

    2/24/26 4:30:00 PM ET
    $HIT
    Specialty Insurers
    Finance

    MARPAI, INC. HIRES PHARMACY EXECUTIVE MIMI DAVIS AS PRESIDENT OF MARPAIRX TO DRIVE STRATEGIC GROWTH

    TAMPA, Fla., Jan. 27, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX:MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced the hiring of Mimi Davis as President of MarpaiRx. Davis, a distinguished leader in the pharmacy services sector, will oversee the strategic expansion and operational scaling of Marpai's pharmacy benefit offerings. Davis joins Marpai from Knipper Health, where she served as Executive Vice President of Operations. Her deep industry roots include a significant tenure at Eagle Pharmacy—a former HillCour portfolio company—which was acquired by Knipper in 2020. With

    1/27/26 8:23:00 AM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care